Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

MeBib Suppressed Methamphetamine Self-Administration Response via Inhibition of BDNF/ERK/CREB Signal Pathway in the Hippocampus

  • Kim, Buyun (College of Pharmacy, Keimyung University) ;
  • Jha, Sonam (College of Pharmacy, Keimyung University) ;
  • Seo, Ji Hae (Department of Biochemistry, School of Medicine, Keimyung University) ;
  • Jeong, Chul-Ho (College of Pharmacy, Keimyung University) ;
  • Lee, Sooyeun (College of Pharmacy, Keimyung University) ;
  • Lee, Sangkil (College of Pharmacy, Keimyung University) ;
  • Seo, Young Ho (College of Pharmacy, Keimyung University) ;
  • Park, Byoungduck (College of Pharmacy, Keimyung University)
  • Received : 2020.03.19
  • Accepted : 2020.05.09
  • Published : 2020.11.01
Download PDF
⟨ Previous Next ⟩

Abstract

Methamphetamine (MA) is one of the most commonly abused drugs in the world by illegal drug users. Addiction to MA is a serious public health problem and effective therapies do not exist to date. It has also been reported that behavior induced by psychostimulants such as MA is related to histone deacetylase (HDAC). MeBib is an HDAC6 inhibitor derived from a benzimidazole scaffold. Many benzimidazole-containing compounds exhibit a wide range of pharmacological activity. In this study, we investigated whether HDAC6 inhibitor MeBib modulates the behavioral response in MA self-administered rats. Our results demonstrated that the number of active lever presses in MA self-administered rats was reduced by pretreatment with MeBib. In the hippocampus of rats, we also found MA administration promotes GluN2B, an NMDA receptor subunit, expression, which results in sequential activation of ERK/CREB/BDNF pathway, however, MeBib abrogated it. Collectively, we suggest that MeBib prevents the MA seeking response induced by MA administration and therefore, represents a potent candidate as an MA addiction inhibitor.

Keywords

References

  1. Abekawa, T., Ohmori, T. and Koyama, T. (1994) Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens. Brain Res. 643, 276-281. https://doi.org/10.1016/0006-8993(94)90033-7
  2. Ashabi, G., Sadat-Shirazi, M. S., Khalifeh, S., Elhampour, L. and Zarrindast, M. R. (2017) NMDA receptor adjusted co-administration of ecstasy and cannabinoid receptor-1 agonist in the amygdala via stimulation of BDNF/Trk-B/CREB pathway in adult male rats. Brain Res. Bull. 130, 221-230. https://doi.org/10.1016/j.brainresbull.2017.01.020
  3. Berberich, S., Jensen, V., Hvalby, O., Seeburg, P. H. and Kohr, G. (2007) The role of NMDAR subtypes and charge transfer during hippocampal LTP induction. Neuropharmacology 52, 77-86. https://doi.org/10.1016/j.neuropharm.2006.07.016
  4. Bhattacharya, S., Mukherjee, B., Dore, J. J. E., Yuan, Q., Harley, C. W. and McLean, J. H. (2017) Histone deacetylase inhibition induces odor preference memory extension and maintains enhanced AMPA receptor expression in the rat pup model. Learn. Mem. 24, 543-551. https://doi.org/10.1101/lm.045799.117
  5. Bowyer, J. F. and Ali, S. (2006) High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus. Synapse 60, 521-532. https://doi.org/10.1002/syn.20324
  6. Brami-Cherrier, K., Valjent, E., Herve, D., Darragh, J., Corvol, J. C., Pages, C., Arthur, S. J., Girault, J. A. and Caboche, J. (2005) Parsing molecular and behavioral effects of cocaine in mitogen- and stress-activated protein kinase-1-deficient mice. J. Neurosci. 25, 11444-11454. https://doi.org/10.1523/JNEUROSCI.1711-05.2005
  7. Cadet, J. L. (2016) Epigenetics of stress, addiction, and resilience: therapeutic implications. Mol. Neurobiol. 53, 545-560. https://doi.org/10.1007/s12035-014-9040-y
  8. Cadet, J. L., Jayanthi, S., McCoy, M. T., Ladenheim, B., Saint-Preux, F., Lehrmann, E., De, S., Becker, K. G. and Brannock, C. (2013) Genome-wide profiling identifies a subset of methamphetamine (METH)-induced genes associated with METH-induced increased H4K5Ac binding in the rat striatum. BMC Genomics 14, 545. https://doi.org/10.1186/1471-2164-14-545
  9. Caldeira, M. V., Melo, C. V., Pereira, D. B., Carvalho, R. F., Carvalho, A. L. and Duarte, C. B. (2007) BDNF regulates the expression and traffic of NMDA receptors in cultured hippocampal neurons. Mol. Cell. Neurosci. 35, 208-219. https://doi.org/10.1016/j.mcn.2007.02.019
  10. Cammarota, M., Bevilaqua, L. R., Medina, J. H. and Izquierdo, I. (2008) ERK1/2 and CaMKII-mediated events in memory formation: is 5HT regulation involved? Behav. Brain Res. 195, 120-128. https://doi.org/10.1016/j.bbr.2007.11.029
  11. Cao, G., Zhu, J., Zhong, Q., Shi, C., Dang, Y., Han, W., Liu, X., Xu, M. and Chen, T. (2013) Distinct roles of methamphetamine in modulating spatial memory consolidation, retrieval, reconsolidation and the accompanying changes of ERK and CREB activation in hippocampus and prefrontal cortex. Neuropharmacology 67, 144-154. https://doi.org/10.1016/j.neuropharm.2012.10.020
  12. Chen, G., Liu, Z., Zhang, Y., Shan, X., Jiang, L., Zhao, Y., He, W., Feng, Z., Yang, S. and Liang, G. (2013) Synthesis and anti-inflammatory evaluation of novel benzimidazole and imidazopyridine derivatives. ACS Med. Chem. Lett. 4, 69-74. https://doi.org/10.1021/ml300282t
  13. da Silveira, F. P., Basso, C., Raupp, W., Dalpiaz, M., Bertoldi, K., Siqueira, I. R., Lago, P. D., de Souza, M. P. and Elsner, V. R. (2017) BDNF levels are increased in peripheral blood of middle-aged amateur runners with no changes on histone H4 acetylation levels. J. Physiol. Sci. 67, 681-687. https://doi.org/10.1007/s12576-016-0496-6
  14. Easmon, J., Puerstinger, G., Roth, T., Fiebig, H. H., Jenny, M., Jaeger, W., Heinisch, G. and Hofmann, J. (2001) 2-benzoxazolyl and 2-benzimidazolyl hydrazones derived from 2-acetylpyridine: a novel class of antitumor agents. Int. J. Cancer 94, 89-96. https://doi.org/10.1002/ijc.1427
  15. Eckroat, T. J., Mayhoub, A. S. and Garneau-Tsodikova, S. (2013) Amyloid-beta probes: review of structure-activity and brain-kinetics relationships. Beilstein J. Org. Chem. 9, 1012-1044. https://doi.org/10.3762/bjoc.9.116
  16. Ersche, K. D., Clark, L., London, M., Robbins, T. W. and Sahakian, B. J. (2006) Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology 31, 1036-1047. https://doi.org/10.1038/sj.npp.1300889
  17. Fernandes, S., Salta, S. and Summavielle, T. (2015) Methamphetamine promotes alpha-tubulin deacetylation in endothelial cells: the protective role of acetyl-l-carnitine. Toxicol. Lett. 234, 131-138. https://doi.org/10.1016/j.toxlet.2015.02.011
  18. Galinato, M. H., Orio, L. and Mandyam, C. D. (2015) Methamphetamine differentially affects BDNF and cell death factors in anatomically defined regions of the hippocampus. Neuroscience 286, 97-108. https://doi.org/10.1016/j.neuroscience.2014.11.042
  19. Go, B. S., Barry, S. M. and McGinty, J. F. (2016) Glutamatergic neurotransmission in the prefrontal cortex mediates the suppressive effect of intra-prelimbic cortical infusion of BDNF on cocaine-seeking. Eur. Neuropsychopharmacol. 26, 1989-1999. https://doi.org/10.1016/j.euroneuro.2016.10.002
  20. Grace, C. E., Schaefer, T. L., Herring, N. R., Skelton, M. R., McCrea, A. E., Vorhees, C. V. and Williams, M. T. (2008) (+)-Methamphetamine increases corticosterone in plasma and BDNF in brain more than forced swim or isolation in neonatal rats. Synapse 62, 110-121. https://doi.org/10.1002/syn.20470
  21. Halpin, L. E., Northrop, N. A. and Yamamoto, B. K. (2014) Ammonia mediates methamphetamine-induced increases in glutamate and excitotoxicity. Neuropsychopharmacology 39, 1031-1038. https://doi.org/10.1038/npp.2013.306
  22. Huo, X. L., Min, J. J., Pan, C. Y., Zhao, C. C., Pan, L. L., Gui, F. F., Jin, L. and Wang, X. T. (2014) Efficacy of lovastatin on learning and memory deficits caused by chronic intermittent hypoxia-hypercapnia: through regulation of NR2B-containing NMDA receptor-ERK pathway. PLoS ONE 9, e94278. https://doi.org/10.1371/journal.pone.0094278
  23. Jang, E. Y., Ryu, Y. H., Lee, B. H., Chang, S. C., Yeo, M. J., Kim, S. H., Folsom, R. J., Schilaty, N. D., Kim, K. J., Yang, C. H., Steffensen, S. C. and Kim, H. Y. (2015) Involvement of reactive oxygen species in cocaine-taking behaviors in rats. Addict. Biol. 20, 663-675. https://doi.org/10.1111/adb.12159
  24. Jayanthi, S., McCoy, M. T., Chen, B., Britt, J. P., Kourrich, S., Yau, H. J., Ladenheim, B., Krasnova, I. N., Bonci, A. and Cadet, J. L. (2014) Methamphetamine downregulates striatal glutamate receptors via diverse epigenetic mechanisms. Biol. Psychiatry 76, 47-56. https://doi.org/10.1016/j.biopsych.2013.09.034
  25. Jing, D., Lee, F. S. and Ninan, I. (2017) The BDNF Val66Met polymorphism enhances glutamatergic transmission but diminishes activity-dependent synaptic plasticity in the dorsolateral striatum. Neuropharmacology 112, 84-93. https://doi.org/10.1016/j.neuropharm.2016.06.030
  26. Kalda, A., Heidmets, L. T., Shen, H. Y., Zharkovsky, A. and Chen, J. F. (2007) Histone deacetylase inhibitors modulates the induction and expression of amphetamine-induced behavioral sensitization partially through an associated learning of the environment in mice. Behav. Brain Res. 181, 76-84. https://doi.org/10.1016/j.bbr.2007.03.027
  27. Kalivas, P. W. and Volkow, N. D. (2011) New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol. Psychiatry 16, 974-986. https://doi.org/10.1038/mp.2011.46
  28. Kim, D. J., Roh, S., Kim, Y., Yoon, S. J., Lee, H. K., Han, C. S. and Kim, Y. K. (2005) High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users. Neurosci. Lett. 388, 112-115. https://doi.org/10.1016/j.neulet.2005.06.042
  29. Krapivinsky, G., Krapivinsky, L., Manasian, Y., Ivanov, A., Tyzio, R., Pellegrino, C., Ben-Ari, Y., Clapham, D. E. and Medina, I. (2003) The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. Neuron 40, 775-784. https://doi.org/10.1016/S0896-6273(03)00645-7
  30. Kuczenski, R., Everall, I. P., Crews, L., Adame, A., Grant, I. and Masliah, E. (2007) Escalating dose-multiple binge methamphetamine exposure results in degeneration of the neocortex and limbic system in the rat. Exp. Neurol. 207, 42-51. https://doi.org/10.1016/j.expneurol.2007.05.023
  31. Lazer, E. S., Matteo, M. R. and Possanza, G. J. (1987) Benzimidazole derivatives with atypical antiinflammatory activity. J. Med. Chem. 30, 726-729. https://doi.org/10.1021/jm00387a026
  32. Li, L., Liu, X., Qiao, C., Chen, G. and Li, T. (2016) Ifenprodil attenuates methamphetamine-induced behavioral sensitization and activation of Ras-ERK-FosB pathway in the caudate putamen. Neurochem. Res. 41, 2636-2644. https://doi.org/10.1007/s11064-016-1976-z
  33. Lin, S. Y., Wu, K., Levine, E. S., Mount, H. T., Suen, P. C. and Black, I. B. (1998) BDNF acutely increases tyrosine phosphorylation of the NMDA receptor subunit 2B in cortical and hippocampal postsynaptic densities. Brain Res. Mol. Brain Res. 55, 20-27. https://doi.org/10.1016/S0169-328X(97)00349-5
  34. Mishra, D., Pena-Bravo, J. I., Leong, K. C., Lavin, A. and Reichel, C. M. (2017) Methamphetamine self-administration modulates glutamate neurophysiology. Brain Struct. Funct. 222, 2031-2039. https://doi.org/10.1007/s00429-016-1322-x
  35. Mizoguchi, H., Yamada, K., Mizuno, M., Mizuno, T., Nitta, A., Noda, Y. and Nabeshima, T. (2004) Regulations of methamphetamine reward by extracellular signal-regulated kinase 1/2/ets-like gene-1 signaling pathway via the activation of dopamine receptors. Mol. Pharmacol. 65, 1293-1301. https://doi.org/10.1124/mol.65.5.1293
  36. Moriguchi, S., Watanabe, S., Kita, H. and Nakanishi, H. (2002) Enhancement of N-methyl- D-aspartate receptor-mediated excitatory postsynaptic potentials in the neostriatum after methamphetamine sensitization. An in vitro slice study. Exp. Brain Res. 144, 238-246. https://doi.org/10.1007/s00221-002-1039-3
  37. Nash, J. F. and Yamamoto, B. K. (1992) Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res. 581, 237-243. https://doi.org/10.1016/0006-8993(92)90713-J
  38. Nestler, E. J. (2001) Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2, 119-128. https://doi.org/10.1038/35053570
  39. Pickens, C. L., Airavaara, M., Theberge, F., Fanous, S., Hope, B. T. and Shaham, Y. (2011) Neurobiology of the incubation of drug craving. Trends Neurosci. 34, 411-420. https://doi.org/10.1016/j.tins.2011.06.001
  40. Qi, J., Han, W. Y., Yang, J. Y., Wang, L. H., Dong, Y. X., Wang, F., Song, M. and Wu, C. F. (2012) Oxytocin regulates changes of extracellular glutamate and GABA levels induced by methamphetamine in the mouse brain. Addict. Biol. 17, 758-769. https://doi.org/10.1111/j.1369-1600.2012.00439.x
  41. Ricoy, U. M. and Martinez, J. L., Jr. (2009) Local hippocampal methamphetamine-induced reinforcement. Front. Behav. Neurosci. 3, 47. https://doi.org/10.3389/neuro.08.047.2009
  42. Rocher, C. and Gardier, A. M. (2001) Effects of repeated systemic administration of d-Fenfluramine on serotonin and glutamate release in rat ventral hippocampus: comparison with methamphetamine using in vivo microdialysis. Naunyn Schmiedebergs Arch. Pharmacol. 363, 422-428. https://doi.org/10.1007/s002100000381
  43. Rosenblum, K., Dudai, Y. and Richter-Levin, G. (1996) Long-term potentiation increases tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit 2B in rat dentate gyrus in vivo. Proc. Natl. Acad. Sci. U.S.A. 93, 10457-10460. https://doi.org/10.1073/pnas.93.19.10457
  44. Rostas, J. A., Brent, V. A., Voss, K., Errington, M. L., Bliss, T. V. and Gurd, J. W. (1996) Enhanced tyrosine phosphorylation of the 2B subunit of the N-methyl-D-aspartate receptor in long-term potentiation. Proc. Natl. Acad. Sci. U.S.A. 93, 10452-10456. https://doi.org/10.1073/pnas.93.19.10452
  45. Sakamoto, K., Karelina, K. and Obrietan, K. (2011) CREB: a multifaceted regulator of neuronal plasticity and protection. J. Neurochem. 116, 1-9. https://doi.org/10.1111/j.1471-4159.2010.07080.x
  46. Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H. and Grant, I. (2007) Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol. Rev. 17, 275-297. https://doi.org/10.1007/s11065-007-9031-0
  47. Seto, E. and Yoshida, M. (2014) Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb. Perspect. Biol. 6, a018713. https://doi.org/10.1101/cshperspect.a018713
  48. Simoes, P. F., Silva, A. P., Pereira, F. C., Marques, E., Milhazes, N., Borges, F., Ribeiro, C. F. and Macedo, T. R. (2008) Methamphetamine changes NMDA and AMPA glutamate receptor subunit levels in the rat striatum and frontal cortex. Ann. N. Y. Acad. Sci. 1139, 232-241. https://doi.org/10.1196/annals.1432.028
  49. Simon, S. L., Dacey, J., Glynn, S., Rawson, R. and Ling, W. (2004) The effect of relapse on cognition in abstinent methamphetamine abusers. J. Subst. Abuse Treat. 27, 59-66. https://doi.org/10.1016/j.jsat.2004.03.011
  50. Skelton, M. R., Williams, M. T., Schaefer, T. L. and Vorhees, C. V. (2007) Neonatal (+)-methamphetamine increases brain derived neurotrophic factor, but not nerve growth factor, during treatment and results in long-term spatial learning deficits. Psychoneuroendocrinology 32, 734-745. https://doi.org/10.1016/j.psyneuen.2007.05.004
  51. Stucky, A., Bakshi, K. P., Friedman, E. and Wang, H. Y. (2016) Prenatal cocaine exposure upregulates BDNF-TrkB signaling. PLoS ONE 11, e0160585. https://doi.org/10.1371/journal.pone.0160585
  52. Thomas, D. M., Walker, P. D., Benjamins, J. A., Geddes, T. J. and Kuhn, D. M. (2004) Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J. Pharmacol. Exp. Ther. 311, 1-7. https://doi.org/10.1124/jpet.104.070961
  53. Torres, O. V., Ladenheim, B., Jayanthi, S., McCoy, M. T., Krasnova, I. N., Vautier, F. A. and Cadet, J. L. (2016) An acute methamphetamine injection downregulates the expression of several histone deacetylases (HDACs) in the mouse nucleus accumbens: potential regulatory role of HDAC2 expression. Neurotox. Res. 30, 32-40. https://doi.org/10.1007/s12640-015-9591-3
  54. Vecsey, C. G., Hawk, J. D., Lattal, K. M., Stein, J. M., Fabian, S. A., Attner, M. A., Cabrera, S. M., McDonough, C. B., Brindle, P. K., Abel, T. and Wood, M. A. (2007) Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J. Neurosci. 27, 6128-6140. https://doi.org/10.1523/JNEUROSCI.0296-07.2007
  55. Walz, C., Jungling, K., Lessmann, V. and Gottmann, K. (2006) Presynaptic plasticity in an immature neocortical network requires NMDA receptor activation and BDNF release. J. Neurophysiol. 96, 3512-3516. https://doi.org/10.1152/jn.00018.2006
  56. Xing, A., Li, X., Jiang, C., Chen, Y., Wu, S., Zhang, J. and An, L. (2019) As a histone deacetylase inhibitor, gamma-aminobutyric acid upregulates GluR2 expression: an in vitro and in vivo study. Mol. Nutr. Food Res. 63, e1900001.
  57. Yeh, G. C., Chen, J. C., Tsai, H. C., Wu, H. H., Lin, C. Y., Hsu, P. C. and Peng, Y. C. (2002) Amphetamine inhibits the N-methyl-D-aspartate receptor-mediated responses by directly interacting with the receptor/channel complex. J. Pharmacol. Exp. Ther. 300, 1008-1016. https://doi.org/10.1124/jpet.300.3.1008
  58. Zhang, S., Jin, Y., Liu, X., Yang, L., Ge, Z., Wang, H., Li, J. and Zheng, J. (2014) Methamphetamine modulates glutamatergic synaptic transmission in rat primary cultured hippocampal neurons. Brain Res. 1582, 1-11. https://doi.org/10.1016/j.brainres.2014.07.040

Cited by

  1. Epigenetic Regulatory Dynamics in Models of Methamphetamine-Use Disorder vol.12, pp.10, 2021, https://doi.org/10.3390/genes12101614